Memphasys Limited (ASX:MEM)
Australia · Delayed Price · Currency is AUD 0.0040
0.00 (0.00%)
Aug 1, 2025, 10:30 AM AEST
Accolade Market Cap
Memphasys has a market cap or net worth of 7.93 million as of August 1, 2025. Its market cap has decreased by -35.54% in one year.
Market Cap
7.93M
Enterprise Value
11.71M
Revenue
1.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 14, 2007, Memphasys's market cap has increased from 5.33M to 7.93M, an increase of 48.90%. That is a compound annual growth rate of 2.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 7.93M | -44.00% |
| Dec 31, 2024 | 14.17M | 4.43% |
| Dec 29, 2023 | 13.57M | 1.01% |
| Dec 30, 2022 | 13.43M | -81.77% |
| Dec 31, 2021 | 73.67M | -2.39% |
| Dec 31, 2020 | 75.48M | 100.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 131.27B |
| Pro Medicus | 33.40B |
| Cochlear | 20.72B |
| Sonic Healthcare | 13.69B |
| Ramsay Health Care | 8.94B |
| Telix Pharmaceuticals | 7.00B |
| Ansell | 4.38B |
| Mesoblast | 3.13B |